EWTX vs. SPRY
EWTX (Edgewise Therapeutics Inc) and SPRY (Silverback Therapeutics Inc) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, EWTX returned 9.21%/yr vs -20.88%/yr for SPRY. At a 0.26 correlation, their price movements are largely independent.
Performance
EWTX vs. SPRY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EWTX achieves a 56.48% return, which is significantly higher than SPRY's -11.76% return.
EWTX
- 1D
- 6.38%
- 1M
- 18.75%
- YTD
- 56.48%
- 6M
- 78.57%
- 1Y
- 173.84%
- 3Y*
- 72.23%
- 5Y*
- 9.21%
- 10Y*
- —
SPRY
- 1D
- 3.01%
- 1M
- 29.47%
- YTD
- -11.76%
- 6M
- -6.80%
- 1Y
- -37.96%
- 3Y*
- 17.85%
- 5Y*
- -20.88%
- 10Y*
- —
EWTX vs. SPRY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
EWTX Edgewise Therapeutics Inc | 56.48% | -7.06% | 144.06% | 22.37% | -41.49% | -43.41% |
SPRY Silverback Therapeutics Inc | -11.76% | 10.43% | 92.52% | -35.76% | 28.08% | -86.68% |
Correlation
The correlation between EWTX and SPRY is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Mar 26, 2021 | 0.26 |
Fundamentals
EWTX:
$4.16B
SPRY:
$1.02B
EWTX:
-$1.67
SPRY:
-$2.00
EWTX:
8.43
SPRY:
16.65
EWTX:
$0.00
SPRY:
$98.99M
EWTX:
$0.00
SPRY:
$59.93M
EWTX:
-$188.16M
SPRY:
-$194.60M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EWTX vs. SPRY — Risk / Return Rank
EWTX
SPRY
EWTX vs. SPRY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Edgewise Therapeutics Inc (EWTX) and Silverback Therapeutics Inc (SPRY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EWTX | SPRY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.91 | ||
| Sortino ratioReturn per unit of downside risk | +3.82 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 0.94 | +0.45 |
| Calmar ratioReturn relative to maximum drawdown | 8.93 | -0.60 | +9.53 |
| Martin ratioReturn relative to average drawdown | 22.39 | -0.85 | +23.25 |
Loading charts...
Drawdowns
EWTX vs. SPRY - Drawdown Comparison
The maximum EWTX drawdown since its inception was -84.69%, smaller than the maximum SPRY drawdown of -95.20%. Use the drawdown chart below to compare losses from any high point for EWTX and SPRY.
Loading charts...
Drawdown Indicators
| EWTX | SPRY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.69% | -95.20% | +10.51% |
Max Drawdown (1Y)Largest decline over 1 year | -19.59% | -63.32% | +43.73% |
Max Drawdown (3Y)Largest decline over 3 years | -68.81% | -63.32% | -5.49% |
Max Drawdown (5Y)Largest decline over 5 years | -77.14% | -91.77% | +14.63% |
Current DrawdownCurrent decline from peak | -3.55% | -82.98% | +79.43% |
Average DrawdownAverage peak-to-trough decline | -53.27% | -78.26% | +24.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.80% | 44.52% | -36.72% |
Volatility
EWTX vs. SPRY - Volatility Comparison
Edgewise Therapeutics Inc (EWTX) has a higher volatility of 22.78% compared to Silverback Therapeutics Inc (SPRY) at 18.34%. This indicates that EWTX's price experiences larger fluctuations and is considered to be riskier than SPRY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EWTX | SPRY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.78% | 18.34% | +4.44% |
Volatility (6M)Calculated over the trailing 6-month period | 55.75% | 45.49% | +10.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.79% | 66.37% | +8.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 81.58% | 80.08% | +1.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.12% | 80.79% | +0.33% |
Dividends
EWTX vs. SPRY - Dividend Comparison
Neither EWTX nor SPRY has paid dividends to shareholders.
Financials
EWTX vs. SPRY - Financials Comparison
This section allows you to compare key financial metrics between Edgewise Therapeutics Inc and Silverback Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
EWTX and SPRY have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EWTX has higher volatility (22.78%) compared to SPRY (18.34%). In terms of maximum drawdown, EWTX dropped -84.69% vs SPRY's -95.20%.
EWTX currently has the higher Sharpe Ratio (2.34 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EWTX and SPRY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer